Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Concerning Nivolumab & Head & Neck squamous cell carcinoma (HNSCC), Nivolumab has both FDA and EMA approvals for use in Head & Neck squamous cell carcinoma (HNSCC) (1)
The anti-PD-1 monoclonal antibody nivolumab can be considered the current standard of care in patients with R/M Head & Neck squamous cell carcinoma (HNSCC) progressing after platinum-based therapy based on the results of CheckMate 141 showing a survival benefit over …